Paratek Pharmaceuticals Files Definitive Proxy Statement and

Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment of $2.15 per Share and a Contingent Value Right of $0.85 per Share on...

Related Keywords

Ukraine , United States , Boston , Massachusetts , Russia , Gurnet Point , China , America , Michael Lampe , Jeffrey Stein , Globenewswire Inc , Development Authority , Exchange Commission , Resistance Merger Sub Inc , Biomedical Advanced Research , Company Annual Report On Form , Linkedin , Morrow Sodali , Transaction Committee , Novo Holdings , Resistance Acquisition Inc , Zai Lab , Paratek Pharmaceuticals , Paratek Pharmaceuticals Inc , Human Services , Twitter , Us Department Of Health , Transaction Provides Paratek Stockholders , Immediate Value , Receive Upfront Cash Payment , Contingent Value Right , Commercial Milestone , Total Potential Value , Point Capital , Fellow Paratek Stockholders , Transaction Delivers , All Cash Consideration , Standalone Alternative Would Likely Result , Substantial Dilution , Robust Process Led , Independent Members , Take Action , Same Effect , Voting Against , Advanced Research , Merger Sub , Merger Agreement , Proxy Statement , Resistance Acquisition , Annual Report , Markets ,